Plasmodium falciparum protein kinase 6 and hemozoin formation are inhibited by a type II human kinase inhibitor exhibiting antimalarial activity
Flore Nardella, Tiantian Jiang, Lushun Wang, Monica J. Bohmer, Subhoja Chakraborty, John Okombo, Jaeson Calla, Tatiane Macedo Silva, Samuel Pažický, Jianwei Che, Jin Yong Jeon, E. J. Vincent, Nonlawat Boonyalai, Rachael Coyle, Mark Buchanan, Samuel Schaefer, Daisy Chen, Amaan Khan, Emily Mayville, Mariana Laureano de Souza, Mayland Treat, Jordan Charlton, Patrick K. Tumwebaze, Seth Tjia, Lukas Montejo, Karen Cover, Philip Rosenthal, Roland A. Cooper, Zbynek Bozdech, Lee M, Ratna Chakrabarti, Sanjay A. Desai, David A. Fidock, Jinhua Wang, Nathanael S. Gray, Elizabeth A. Winzeler, Debopam Chakrabarti
Topics & Concepts
HemozoinPlasmodium falciparumProtein kinase AKinasePharmacologyPlasmodium bergheiBiologyBiochemistryIn vivoHemeChemistryEnzymeMalariaImmunologyBiotechnologyMalaria Research and ControlMosquito-borne diseases and controlComputational Drug Discovery Methods